The Center for Breakthrough Medicines (CBM) and the University of Pennsylvania's Gene Therapy Program (GTP) have signed a landmark collaboration agreement, to combine Penn's...
BioLife Solutions, Inc., a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets, announced an...
Variant, a company dedicated to developing innovative treatments for inherited eye orphan diseases, announces the decision of the European Commission to grant Orphan Drug...
